Sign Up to like & get
recommendations!
2
Published in 2022 at "Brain Pathology"
DOI: 10.1111/bpa.13107
Abstract: Telomerase reverse transcriptase (TERT) promoter (pTERT) mutation has often been described as a late event in gliomagenesis and it has been suggested as a prognostic biomarker in gliomas other than 1p19q codeleted tumors. However, the…
read more here.
Keywords:
adult;
glioblastomas;
amplification;
idhwt ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.869061
Abstract: Background Although isocitrate dehydrogenase (IDH) mutation serves as a prognostic signature for routine clinical management of glioma, nearly 90% of glioblastomas (GBM) patients have a wild-type IDH genotype (IDHWT) and lack reliable signatures to identify…
read more here.
Keywords:
signature;
expression levels;
risk;
idhwt ... See more keywords